vs

Side-by-side financial comparison of Almonty Industries Inc. (ALM) and RYTHM, Inc. (RYM). Click either name above to swap in a different company.

RYTHM, Inc. is the larger business by last-quarter revenue ($10.7M vs $6.3M, roughly 1.7× Almonty Industries Inc.). Almonty Industries Inc. runs the higher net margin — -86.1% vs -127.6%, a 41.6% gap on every dollar of revenue.

Almonty Industries Inc. is an international mining company primarily engaged in the extraction and development of tungsten resources. The company operates in Spain, Portugal, and South Korea and is publicly traded on the Toronto Stock Exchange (TSX). The current Chief Executive Officer is Lewis Black.

RYTHM, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for rare genetic endocrine and metabolic disorders with high unmet medical needs. It primarily operates in the U.S. market, targeting pediatric and adult patient segments that lack standard effective treatment options.

ALM vs RYM — Head-to-Head

Bigger by revenue
RYM
RYM
1.7× larger
RYM
$10.7M
$6.3M
ALM
Higher net margin
ALM
ALM
41.6% more per $
ALM
-86.1%
-127.6%
RYM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ALM
ALM
RYM
RYM
Revenue
$6.3M
$10.7M
Net Profit
$-5.4M
$-13.6M
Gross Margin
75.5%
Operating Margin
-121.5%
Net Margin
-86.1%
-127.6%
Revenue YoY
242.0%
Net Profit YoY
44.1%
EPS (diluted)
$-6.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALM
ALM
RYM
RYM
Q4 25
$10.7M
Q3 25
$6.3M
$4.0M
Q2 25
$7.2M
$2.0M
Q1 25
$538.0K
Q4 24
$-7.5M
Q3 24
$1.9M
Q2 24
$3.0M
Q1 24
$2.6M
Net Profit
ALM
ALM
RYM
RYM
Q4 25
$-13.6M
Q3 25
$-5.4M
$-10.7M
Q2 25
$-58.2M
$-7.4M
Q1 25
$-1.6M
Q4 24
$-24.4M
Q3 24
$-18.7M
Q2 24
$-3.0M
Q1 24
$4.2M
Gross Margin
ALM
ALM
RYM
RYM
Q4 25
75.5%
Q3 25
34.0%
Q2 25
33.4%
Q1 25
16.7%
Q4 24
Q3 24
11.6%
Q2 24
37.6%
Q1 24
6.4%
Operating Margin
ALM
ALM
RYM
RYM
Q4 25
-121.5%
Q3 25
-219.8%
Q2 25
-332.9%
Q1 25
-687.9%
Q4 24
Q3 24
-63.1%
Q2 24
-28.5%
Q1 24
13.6%
Net Margin
ALM
ALM
RYM
RYM
Q4 25
-127.6%
Q3 25
-86.1%
-263.8%
Q2 25
-809.4%
-360.4%
Q1 25
-302.2%
Q4 24
324.4%
Q3 24
-964.4%
Q2 24
-99.3%
Q1 24
163.0%
EPS (diluted)
ALM
ALM
RYM
RYM
Q4 25
$-6.78
Q3 25
$-5.33
Q2 25
$-3.74
Q1 25
$-0.83
Q4 24
$-24.26
Q3 24
$-17.28
Q2 24
$-3.16
Q1 24
$3.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALM
ALM
RYM
RYM
Cash + ST InvestmentsLiquidity on hand
$32.2M
Total DebtLower is stronger
$80.6M
Stockholders' EquityBook value
$13.0M
Total Assets
$106.7M
Debt / EquityLower = less leverage
6.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALM
ALM
RYM
RYM
Q4 25
$32.2M
Q3 25
Q2 25
$41.0M
Q1 25
$24.4M
Q4 24
Q3 24
$267.0K
Q2 24
$57.0K
Q1 24
$99.0K
Total Debt
ALM
ALM
RYM
RYM
Q4 25
$80.6M
Q3 25
$90.6M
Q2 25
$40.6M
Q1 25
$10.6M
Q4 24
Q3 24
$6.2M
Q2 24
$4.6M
Q1 24
Stockholders' Equity
ALM
ALM
RYM
RYM
Q4 25
$13.0M
Q3 25
$11.7M
Q2 25
$21.0M
Q1 25
$26.8M
Q4 24
$28.1M
Q3 24
$5.5M
Q2 24
$8.5M
Q1 24
$-5.5M
Total Assets
ALM
ALM
RYM
RYM
Q4 25
$106.7M
Q3 25
$115.2M
Q2 25
$69.5M
Q1 25
$45.6M
Q4 24
$54.0M
Q3 24
$39.0M
Q2 24
$39.4M
Q1 24
$40.6M
Debt / Equity
ALM
ALM
RYM
RYM
Q4 25
6.19×
Q3 25
7.73×
Q2 25
1.94×
Q1 25
0.40×
Q4 24
Q3 24
1.13×
Q2 24
0.54×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALM
ALM
RYM
RYM
Operating Cash FlowLast quarter
$-3.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALM
ALM
RYM
RYM
Q4 25
$-3.0M
Q3 25
$-5.4M
Q2 25
$-8.4M
Q1 25
$-6.7M
Q4 24
$-5.3M
Q3 24
$-1.4M
Q2 24
$-1.8M
Q1 24
$-3.0M
Free Cash Flow
ALM
ALM
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-1.8M
Q1 24
$-3.0M
FCF Margin
ALM
ALM
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-61.2%
Q1 24
-115.1%
Capex Intensity
ALM
ALM
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
ALM
ALM
RYM
RYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALM
ALM

Segment breakdown not available.

RYM
RYM

Nonlicensing Revenue$9.5M89%
Cultivation Business Discontinued Operations$1.2M11%

Related Comparisons